Drug locally used for tracheal stenosis
The core concept here is probably related to local drug administration for managing tracheal stenosis. Local drugs in the trachea would be applied directly, maybe via nebulization, injection, or during procedures like bronchoscopy. Common drugs for stenosis might include corticosteroids to reduce inflammation, or maybe something like mitomycin C, which is a chemotherapeutic agent used in some surgical contexts to prevent scarring.
The correct answer is likely mitomycin C. I remember that mitomycin C is used in endoscopic treatments for conditions like subglottic stenosis or tracheal stenosis. It's a topical chemotherapeutic agent that inhibits fibroblast proliferation, thereby reducing scar tissue formation after procedures like dilation or stent placement.
Now, the options are A, B, C, D, but they aren't provided. However, common distractors might include systemic corticosteroids, which are used but not local. Or maybe something like epinephrine, which isn't typically used for stenosis. Other options could be antibiotics or antifungals if the question is trying to trick us into thinking about infection, but the main treatment is anti-inflammatory or antifibrotic.
So, why is mitomycin C the right answer? Because it's applied locally during procedures to prevent restenosis by inhibiting cell proliferation. Its mechanism involves cross-linking DNA, which stops cell division. This is crucial in preventing the scar tissue that causes the stenosis to recur.
For the incorrect options: if someone chose a systemic corticosteroid like prednisone, that's incorrect because the question specifies a local drug. Another wrong option might be a bronchodilator like albuterol, which doesn't address stenosis. An antibiotic like amoxicillin would be wrong because stenosis is not primarily an infection. A beta-blocker like propranolol is also irrelevant here.
The clinical pearl here is that mitomycin C is a high-yield fact for tracheal stenosis management, especially in endoscopic procedures. Remembering that it's used topically to prevent scar tissue is key. Also, differentiating between local and systemic treatments is important for the exam.
**Core Concept**
Tracheal stenosis involves narrowing of the trachea, often requiring local pharmacological intervention to reduce fibrosis or inflammation. **Mitomycin C**, a chemotherapeutic agent, is applied topically during bronchoscopy to inhibit fibroblast proliferation and prevent restenosis after dilation or surgery.
**Why the Correct Answer is Right**
Mitomycin C is a DNA cross-linking agent that inhibits DNA synthesis in rapidly dividing fibroblasts. When applied directly to the tracheal mucosa during procedures like balloon dilation or stent placement, it reduces post-procedural scarring and granulation tissue formation. This is critical in managing recurrent stenosis caused by conditions like post-intubation injury or